![Joan Brandt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joan Brandt worked as a Principal at MedImmune LLC from 2001 to 2009.
She also worked as a Vice President of Quality Control at Parkedale Pharmaceuticals, Inc. and as a Vice President of Quality at MacroGenics, Inc. Additionally, she worked as a Principal at Baxter Hyland Immuno.
Dr. Brandt holds a doctorate degree from The Catholic University of America.
| Unternehmen | Position | Ende |
|---|---|---|
Baxter Hyland Immuno | Corporate Officer/Principal | - |
MedImmune LLC
 MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Corporate Officer/Principal | - |
Parkedale Pharmaceuticals, Inc. | Corporate Officer/Principal | - |
| MACROGENICS, INC. | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 5 |
|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Parkedale Pharmaceuticals, Inc. | |
MacroGenics, Inc.
 MacroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes antibody-based therapeutics for the treatment of cancer | Health Technology |
The Catholic University of America
 The Catholic University of America Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baxter Hyland Immuno |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
